Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
5 hedge funds and large institutions have $324K invested in Genetic Technologies Ltd. in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
23% more capital invested
Capital invested by funds: $263K → $324K (+$61K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$104K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Cutler Group
San Francisco,
California
|
-$1.59K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$794 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $321K | +$104K | +6,559 | +25% |
|
|
DCM
2
Davis Capital Management
Jacksonville,
Florida
| $2K | +$3.18K | +200 | New |
|
|
CG
3
Cutler Group
San Francisco,
California
| $1K | -$1.59K | -100 | -38% |
|
|
RE
4
RBC Europe
London,
United Kingdom
| $39 | – | – | – |
|
|
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1K | -200 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$794 | -50 | -77% |
|
GENE Hedge Fund Activity: Q1 2020 in Review
5 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q1 2020, worth a combined $324K — up 23% from $263K a quarter earlier.
Fund positioning in GENE was balanced in Q1 2020: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $104K. The largest seller was Cutler Group, cutting an estimated $1.59K.
- 5 institutional investors held Genetic Technologies Ltd. (GENE) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $324K of Genetic Technologies Ltd. stock for Q1 2020, up 23% quarter-over-quarter.
- 1 fund opened new Genetic Technologies Ltd. positions in Q1 2020 and 1 closed out, a net change of 0 holders.
- The largest Genetic Technologies Ltd. buyer in Q1 2020 was Renaissance Technologies, an estimated $104K added.
- The largest Genetic Technologies Ltd. seller in Q1 2020 was Cutler Group, an estimated $1.59K sold.
Based on aggregated 13F filings for Q1 2020.